Series

A 3D rendering of multiple blue cells floating in a microscopic environment, depicting detailed cellular structures.

Part 2: The Invention of PCR

2026.01.06
The author first heard the term “PCR” in the early 1980s while undergoing training on a DNA synthesizer in the sub… 黒澤伸行

青色の細胞が多数浮遊している様子を表した3Dイメージ画像。顕微鏡観察をモデル化した細胞構造のレンダリング

Part 1 The “Analyzing Life’s Mysteries” Project Was Born from Analytical Instrument Development

2025.11.17
This series is based on a manuscript I had the honor of writing for the Journal of the Society for Biotechnology, Japan, “Continuation of the Fundamentals of Biotechnology Lecture Series/Miscel… 黒澤伸行

DNAの二重らせんと、カラフルなブロック状要素が連なるタンパク質構造を組み合わせた、タンパク質の仕組みを象徴的に表現したコンセプトビジュアル。

Exploring the Mysteries of Proteins — A Journey into Function and Structure (Part 1)

2025.12.17
What Are Proteins, Really? When you hear the word “protein,” you may first think of food or nutrition. In reality, however, proteins are molecu… 黒澤伸行

Introductory Knowledge of Intellectual Property in Life Sciences – The Essential Relationship Between Medicines and Patents

Vol. 7: Wait what? You can squash a patent? – How to Defeat Patents That Block Advances in Life Science Business-

2025.11.30
Last time, we discussed patent litigation. The most powerful counteraction when accused of patent infringement is to “squash the patent” — that is, to invalidate it. If the patent can be invalidated, the rights that … 黒澤伸行

Vol. 6: Sued for Patent Infringement? – Here’s How the Litigation would Unfold –

2025.11.01
Unlike the United States—a country known for its litigious culture – Japan sees relatively few patent lawsuits. However, the situation is somewhat different in the life sciences sector. In May of this year, a high-profile p… 黒澤伸行

Vol. 5: Do they really creep in? – Development schedules of Generics and Biosimilars

2025.09.30
This time, we are going to talk about generic drugs and biosimilars. These days in Japan we don't hear the word "zoro", but up until about 20 years ago, generic drugs were commonly referred to as "zoro." The word “zoro” stems … 黒澤伸行

Vol. 4: What do you mean “patents can be extended”? – Patent Term Extension: A special system for pharma–

2025.09.01
Last time, we discussed how to obtain a patent, following the process from application to obtaining a patent. I touched on the length of a patent term at the end. Do you remember how long a patent term was? The answer is 20… 黒澤伸行

Vol. 3: Shall we talk about how to obtain a patent? – Process flow from patent application to obtaining a patent –

2025.07.31
So far, we’ve explored the medicine classification and patents (Vol. 1), and the reasons why Medicines and Patents are inseparable (Vol. 2). In this volume, the spotlight fa… 黒澤伸行

Vol. 2: Wow! The success rate of drug development is shockingly low!

2025.07.01
In the previous volume, we discussed the types of pharmaceutical medicines and patents, so you will remember that “new drugs” are brand drugs under the category of ethical drugs… 黒澤伸行

Vol. 1: First, let’s talk about medicine classification and patents

2025.05.30
Most people understand that patents are important in the life sciences industry, including pharmaceuticals and biotechnology. However, many might feel that the complexities of patents make them difficult … 黒澤伸行

Part 2: The Invention of PCR

Part 1 The “Analyzing Life’s Mysteries” Project Was Born from Analytical Instrument Development

Exploring the Mysteries of Proteins — A Journey into Function and Structure (Part 1)

Vol. 7: Wait what? You can squash a patent? – How to Defeat Patents That Block Advances in Life Science Business-

Vol. 6: Sued for Patent Infringement? – Here’s How the Litigation would Unfold –

Vol. 5: Do they really creep in? – Development schedules of Generics and Biosimilars

Vol. 4: What do you mean “patents can be extended”? – Patent Term Extension: A special system for pharma–

Vol. 3: Shall we talk about how to obtain a patent? – Process flow from patent application to obtaining a patent –

Vol. 2: Wow! The success rate of drug development is shockingly low!

Vol. 1: First, let’s talk about medicine classification and patents

Popular articles/人気記事

Recent Posts/最近の投稿

Event Schedule

Series

Part 2: The Invention of PCR

Part 1 The “Analyzing Life’s Mysteries” Project Was Born from Analytical Instrument Development

Exploring the Mysteries of Proteins — A Journey into Function and Structure (Part 1)

Vol. 7: Wait what? You can squash a patent? – How to Defeat Patents That Block Advances in Life Science Business-

Vol. 6: Sued for Patent Infringement? – Here’s How the Litigation would Unfold –

Vol. 5: Do they really creep in? – Development schedules of Generics and Biosimilars

Vol. 4: What do you mean “patents can be extended”? – Patent Term Extension: A special system for pharma–

Vol. 3: Shall we talk about how to obtain a patent? – Process flow from patent application to obtaining a patent –

Vol. 2: Wow! The success rate of drug development is shockingly low!

Vol. 1: First, let’s talk about medicine classification and patents

Popular articles/人気記事

Recent Posts/最近の投稿

Event Schedule

Tag Cloud